Optilight IPL

Lumenis, the inventor of IPL, presents the The first and only FDA approved light therapy for dry eye management. OptiLight is a light-based treatment that uses precise, intense broad spectrum light to address signs of dry eye disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease, accounting for about 86% of cases. The treatment addresses inflammation, which is one of the key underlying factors in MGD. OptiLight was specifically developed to reach the delicate contours of the treated area safely, effectively, and gently using the OPT™ technology.

How It Works

OptiLight is a multi-factorial treatment for a multi-factorial disease. It addresses the disease by reducing major sources of inflammation leading to dry eye disease such as abnormal blood vessels, Demodex mites, and pro-inflammatory agents. OptiLight restores the function of meibomian glands and delays evaporation of the tear film.

Lumenis’ patented technology OPT™ (Optimal Pulse Technology) transforms the use of light and allows targeted, uniform, precise, and controlled treatment. Specifically designed for the delicate area below the eye, OPT™ safely and effectively breaks the vicious cycle of inflammation associated with dry eye.

Frequently Asked Questions

Prioritizing Preventative & Ocular Wellness for Your Family

A MEMBER OF
  • 2570 Blackmon Dr.
    Decatur, GA 30033
Hours
Monday
9:00am – 6:00pm
Tuesday
9:00am – 1:00pm
Wednesday
9:00am – 6:00pm
Thursday
9:00am – 6:00pm
Friday
9:00am – 6:00pm
Saturday
By Appointment Only
Sunday
Closed
©2024 Specs Appeal | Built by FirstPage Marketing